These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs: A Systematic Review and Pooled Analysis. Gyawali B; Tessema FA; Jung EH; Kesselheim AS JAMA Netw Open; 2019 Aug; 2(8):e199570. PubMed ID: 31469391 [TBL] [Abstract][Full Text] [Related]
8. Ensuring Superior Reporting of Radiation Therapy Noninferiority Trials: A Systematic Review. Arifin AJ; Tan VS; Yan M; Warner A; Boldt RG; Chen H; Rodrigues GB; Palma DA; Louie AV Adv Radiat Oncol; 2023; 8(3):101178. PubMed ID: 36852015 [TBL] [Abstract][Full Text] [Related]
9. Mixed noninferiority margin and statistical tests in active controlled trials. Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228 [TBL] [Abstract][Full Text] [Related]
10. Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery Revascularization. Brophy JM JAMA Intern Med; 2020 Jul; 180(7):986-992. PubMed ID: 32478838 [TBL] [Abstract][Full Text] [Related]
11. Misleading Reporting (Spin) in Noninferiority Randomized Clinical Trials in Oncology With Statistically Not Significant Results: A Systematic Review. Ito C; Hashimoto A; Uemura K; Oba K JAMA Netw Open; 2021 Dec; 4(12):e2135765. PubMed ID: 34874407 [TBL] [Abstract][Full Text] [Related]
12. Noninferiority Margins in Trials of Thrombectomy Devices for Acute Ischemic Stroke: Is the Bar Being Set Too Low? Lin CJ; Saver JL Stroke; 2019 Dec; 50(12):3519-3526. PubMed ID: 31619155 [TBL] [Abstract][Full Text] [Related]
13. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. Stone GW; Sabik JF; Serruys PW; Simonton CA; Généreux P; Puskas J; Kandzari DE; Morice MC; Lembo N; Brown WM; Taggart DP; Banning A; Merkely B; Horkay F; Boonstra PW; van Boven AJ; Ungi I; Bogáts G; Mansour S; Noiseux N; Sabaté M; Pomar J; Hickey M; Gershlick A; Buszman P; Bochenek A; Schampaert E; Pagé P; Dressler O; Kosmidou I; Mehran R; Pocock SJ; Kappetein AP; N Engl J Med; 2016 Dec; 375(23):2223-2235. PubMed ID: 27797291 [TBL] [Abstract][Full Text] [Related]
14. Noninferiority Margin Size and Acceptance of Trial Results: Contingent Valuation Survey of Clinician Preferences for Noninferior Mortality. Pong S; Fowler RA; Mitsakakis N; Murthy S; Pernica JM; Gilfoyle E; Bowen A; Fontela P; Seto W; Science M; Hutchison JS; Jouvet P; Rishu A; Daneman N Med Decis Making; 2022 Aug; 42(6):832-836. PubMed ID: 35583116 [TBL] [Abstract][Full Text] [Related]
15. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL; JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257 [TBL] [Abstract][Full Text] [Related]
16. Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials: A Systematic Review. Olivier CB; Struß L; Sünnen N; Kaier K; Heger LA; Westermann D; Meerpohl JJ; Mahaffey KW JAMA Netw Open; 2024 Apr; 7(4):e248818. PubMed ID: 38687478 [TBL] [Abstract][Full Text] [Related]
17. Noninferiority margins exceed superiority effect estimates for mortality in cardiovascular trials in high-impact journals. Ofori S; Cafaro T; Devereaux PJ; Marcucci M; Mbuagbaw L; Thabane L; Guyatt G J Clin Epidemiol; 2023 Sep; 161():20-27. PubMed ID: 37421996 [TBL] [Abstract][Full Text] [Related]
18. A critical analysis of the noninferiority design of the TALENT trial. Saha S; Kerkar P; Gogtay NJ Indian Heart J; 2020; 72(1):52-54. PubMed ID: 32423561 [TBL] [Abstract][Full Text] [Related]